In studies, upper respiratory tract infections and high blood cholesterol levels (hypercholesterolemia) occurred in more than 10% of patients. Less common side effects included other infections such as herpes zoster, herpes simplex, urinary tract infections, and gastroenteritis.
Baricitinib
Abrocitinib
Erdafitinib
Upadacitinib
Gilteritinib
Delgocitinib
Brigatinib
Selpercatinib